drugset / Trial / NCT02708394
Molecular Mechanisms of Antipsychotic-induced Insulin Resistance
RandomizedParallel-groupTriple-blindOther
Summary
This study will investigate the molecular mechanisms of atypical-antipsychotic induced insulin resistance. This will be accomplished by administering olanzapine or placebo to healthy subjects for 7 days and analyzing genetic and protein changes in peripheral tissues known to play an important role in insulin resistance pathophysiology.
Timeline
- Start
- 2017-02-01
- Primary completion
- 2023-10-01
- Completion
- 2023-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olanzapine | Small molecule | — | — |
Indications
No indication recorded.